Skip to main content

CORRECTION article

Front. Microbiol., 23 August 2024
Sec. Virology

Corrigendum: SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge

\r\nYoshie Hosaka&#x;Yoshie Hosaka1Yan Yan&#x;Yan Yan2Toshio Naito,
Toshio Naito2,3*Rieko OyamaRieko Oyama3Koji TsuchiyaKoji Tsuchiya1Norio YamamotoNorio Yamamoto4Shuko NojiriShuko Nojiri5Satoshi HoriSatoshi Hori6Kazuhisa Takahashi,Kazuhisa Takahashi3,7Yoko Tabe,Yoko Tabe1,3
  • 1Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan
  • 2Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan
  • 3Department of Research Support Utilizing Bioresource Bank, Juntendo University Faculty of Medicine, Tokyo, Japan
  • 4Department of Microbiology, Tokai University School of Medicine, Hiratsuka, Kanagawa, Japan
  • 5Medical Technology Innovation Center, Juntendo University Faculty of Medicine, Tokyo, Japan
  • 6Infection Control Unit, Juntendo University Hospital, Tokyo, Japan
  • 7Department of Respiratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan

A Corrigendum on
SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge

Hosaka, Y., Yan, Y., Naito, T., Oyama, R., Tsuchiya, K., Yamamoto, N., Nojiri, S., Hori, S., Takahashi, K., and Tabe, Y. (2023). Front. Microbiol. 14:944369. doi: 10.3389/fmicb.2023.944369

In the published article, an author name was incorrectly written as Kazuhiko Takahashi. The correct spelling is Kazuhisa Takahashi.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, Delta variant, AY.29, immunosuppression, mutation, genome sequencing, nosocomial cluster

Citation: Hosaka Y, Yan Y, Naito T, Oyama R, Tsuchiya K, Yamamoto N, Nojiri S, Hori S, Takahashi K and Tabe Y (2024) Corrigendum: SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge. Front. Microbiol. 15:1478638. doi: 10.3389/fmicb.2024.1478638

Received: 10 August 2024; Accepted: 12 August 2024;
Published: 23 August 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Hosaka, Yan, Naito, Oyama, Tsuchiya, Yamamoto, Nojiri, Hori, Takahashi and Tabe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Toshio Naito, naito@juntendo.ac.jp

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.